 vitro activ tosufloxacin new quinolon respiratori pathogen cystic fibrosi sputum microdilut method vitro activ tosufloxacin new quinolon agent quinolon divers cystic fibrosi sputum isol cystic fibrosi center unit pseudomona aeruginosa convent resist ceftazidim aztreonam gentamicin and/or tobramycin escherichia coli pseudomona cepacia staphylococcu haemophilu influenza tosufloxacin mic isol standard aeruginosa mg/liter resist aeruginosa mg/liter coli equal mg/liter cepacia mg/liter mg/liter influenza equal mg/liter tosufloxacin activ standard resist strain aeruginosa similar compar quinolon against coli tosufloxacin activ similar quinolon against aureu tosufloxacin activ similar trimethoprim-sulfamethoxazol cephalexin tosufloxacin activ agent against influenza tosufloxacin activ similar quinolon minor diminut activ pH major diminut activ pH inoculum size equal cfu/ml activ sputum serum omiss cation supplement tosufloxacin consist activ common cystic fibrosi pathogen high degre activ aureu activ aeruginosa gram-neg bacteria interest vitro studi assess activ vivo model cystic fibrosi pulmonari infect